Yayın:
Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes

dc.contributor.authorYılmaz, Ünsal
dc.contributor.authorGücüyener, Kıvılcım
dc.contributor.authorYavuz, Merve
dc.contributor.authorÖncel, İbrahim
dc.contributor.authorCanpolat, Mehmet
dc.contributor.authorSaltık, Sema
dc.contributor.authorUnver, Olcay
dc.contributor.authorKurt, Ayşegül Neşe Çıtak
dc.contributor.authorTosun, Ayşe
dc.contributor.authorYilmaz, Sanem
dc.contributor.authorÖzgör, Bilge
dc.contributor.authorErol, İlknur
dc.contributor.authorÖztoprak, Ulkuhan
dc.contributor.authorElitez, Duygu Aykol
dc.contributor.authorDirek, Meltem Çobanoğulları
dc.contributor.authorBodur, Muhittin
dc.contributor.authorTeber, Serap
dc.contributor.authorAnlar, Banu
dc.contributor.buuauthorBODUR, MUHİTTİN
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.departmentÇocuk Nörolojisi Bilim Dalı
dc.contributor.orcid0000-0002-2588-8195
dc.contributor.researcheridJAN-9435-2023
dc.date.accessioned2024-11-27T10:45:20Z
dc.date.available2024-11-27T10:45:20Z
dc.date.issued2022-09-19
dc.description.abstractBackground: The discovery of anti-myelin oligodendrocyte glycoprotein (MOG)-IgG and anti-aquaporin 4 (AQP4)-IgG and the observation on certain patients previously diagnosed with multiple sclerosis (MS) actually have an antibody-mediated disease mandated re-evaluation of pediatric MS series. Aim: To describe the characteristics of recent pediatric MS cases by age groups and compare with the cohort established before 2015. Method: Data of pediatric MS patients diagnosed between 2015 and 2021 were collected from 44 pediatric neurology centers across Turkiye. Clinical and paraclinical features were compared between patients with dis-ease onset before 12 years (earlier onset) and >= 12 years (later onset) as well as between our current (2015-2021) and previous (< 2015) cohorts. Results: A total of 634 children (456 girls) were enrolled, 89 (14%) were of earlier onset. The earlier-onset group had lower female/male ratio, more frequent initial diagnosis of acute disseminated encephalomyelitis (ADEM), more frequent brainstem symptoms, longer interval between the first two attacks, less frequent spinal cord involvement on magnetic resonance imaging (MRI), and lower prevalence of cerebrospinal fluid (CSF)-restricted oligoclonal bands (OCBs). The earlier-onset group was less likely to respond to initial disease-modifying treatments. Compared to our previous cohort, the current series had fewer patients with onset < 12 years, initial presentation with ADEM-like features, brainstem or cerebellar symptoms, seizures, and spinal lesions on MRI. The female/male ratio, the frequency of sensorial symptoms, and CSF-restricted OCBs were higher than reported in our previous cohort. Conclusion: Pediatric MS starting before 12 years was less common than reported previously, likely due to exclusion of patients with antibody-mediated diseases. The results underline the importance of antibody testing and indicate pediatric MS may be a more homogeneous disorder and more similar to adult-onset MS than previously thought.
dc.identifier.doi10.1016/j.ejpn.2022.08.006
dc.identifier.eissn1532-2130
dc.identifier.endpage18
dc.identifier.issn1090-3798
dc.identifier.scopus2-s2.0-85143379946
dc.identifier.startpage8
dc.identifier.urihttps://doi.org/10.1016/j.ejpn.2022.08.006
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1090379822001246
dc.identifier.urihttps://hdl.handle.net/11452/48566
dc.identifier.volume41
dc.identifier.wos000860343300002
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherElsevier
dc.relation.journalEuropean Journal of Paediatric Neurology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectVitamin-d status
dc.subjectClinical-features
dc.subjectRelapse rate
dc.subjectChildren
dc.subjectOnset
dc.subjectRisk
dc.subjectChildhood
dc.subjectDisease
dc.subjectDiagnosis
dc.subjectRevisions
dc.subjectPediatric multiple sclerosis
dc.subjectAnti-mog-igg
dc.subjectAnti-aqp4-igg
dc.subjectAntibody
dc.subjectDemyelinating
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectClinical neurology
dc.subjectPediatrics
dc.subjectNeurosciences & neurology
dc.titleRe-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı/Çocuk Nörolojisi Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication6a7d0ca4-dd18-4890-86fa-1b5a7bd0c4f1
relation.isAuthorOfPublication.latestForDiscovery6a7d0ca4-dd18-4890-86fa-1b5a7bd0c4f1

Dosyalar